Physician profile
Aysha Arshad
NPI 1710964960
$42,554.35
in general payments reported to CMS, 2019-2025
41 companies · $10K in 2025
The $10K reported for 2025 was more than what 81% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $6,428 · 2020: $8,384 · 2021: $1,615 · 2022: $8,762 · 2023: $3,793 · 2024: $3,223 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $5,309 · Consulting Fee: $1,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,167.84 |
| Travel and Lodging | $5,309.29 |
| Consulting Fee | $1,888.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18,581.52 | 2019-2025 | Navitor, Aveir, Na |
| Medtronic, INC. | $8,157.10 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Evera Mri Xt Dr Surescan, Affera Mapping System |
| Medtronic Vascular, INC. | $4,770.54 | 2019-2020 | |
| Cvrx, INC. | $3,524.15 | 2021-2025 | Barostim Neo System |
| Boston Scientific Corporation | $1,056.17 | 2019-2025 | Watchman Access System, General - Therapies, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $719.38 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $530.56 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $512.19 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Philips North America LLC | $428.74 | 2019-2022 | |
| Pfizer INC. | $410.67 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $385.82 | 2022-2023 | Xarelto |
| Amgen INC. | $326.52 | 2019-2025 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $322.75 | 2023-2025 | Farxiga, Lokelma, Brilinta |
| Novartis Pharmaceuticals Corporation | $291.60 | 2021-2025 | |
| Scpharmaceuticals INC. | $270.92 | 2024-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $255.15 | 2023-2025 | Assure Wcd |
| Bridgebio Pharma, INC. | $176.54 | 2025 | Attruby |
| Atricure, INC. | $161.78 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $158.36 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $157.62 | 2023-2025 | Verquvo, Capvaxive |
| Biosense Webster, INC. | $145.33 | 2024-2025 | Carto 3, Nuvision Ice Catheter |
| Zoll Respicardia, INC. | $136.39 | 2021 | |
| Lilly USA, LLC | $124.51 | 2025 | |
| Ionis Pharmaceuticals, INC. | $122.03 | 2025 | Tryngolza |
| Bayer Healthcare Pharmaceuticals INC. | $118.98 | 2025 | |
| Cardiva Medical, INC. | $118.87 | 2020 | |
| Esperion Therapeutics, INC. | $115.60 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.21 | 2022 | |
| Baxter Healthcare | $101.14 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $65.54 | 2019 | |
| Recor Medical INC | $28.00 | 2025 | Paradise Ultrasound Renal Denervation System |
| Daiichi Sankyo INC. | $25.00 | 2024 | Injectafer |
| Cardiovascular Systems INC. | $24.54 | 2022 | |
| Qorumpartners | $20.05 | 2022 | |
| Abiomed | $19.22 | 2024 | Impella |
| Bardy Diagnostics, INC. | $17.20 | 2022 | |
| Smith+Nephew, INC. | $16.25 | 2023 | Pico 7 |
| Glaxosmithkline, LLC. | $16.09 | 2025 | Shingrix, Arexvy |
| Chiesi USA, INC. | $15.30 | 2024 | Kengreal |
| Vivaquant INC, Dba Rhythm Express | $12.64 | 2024 | Rhythm Express |
| Altathera Pharmaceuticals LLC | $11.38 | 2024 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13,650.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aysha Arshad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.